Whitehouse Station, NJ, United States of America

Imre M Vitez

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Imre M Vitez. Retrieved from https://idiyas.com/inventor/imre-m-vitez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Imre M Vitez: Innovator in Pharmaceutical Polymorphs

Introduction

Imre M Vitez is a notable inventor based in Whitehouse Station, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline polymorphs.

Latest Patents

Imre M Vitez holds 3 patents. His latest patents include innovative work on polymorphs of an epothilone analog. These patents describe two crystalline polymorphs, designated Form A and Form B, along with methods for forming these novel polymorphs. Additionally, therapeutic methods utilizing these polymorphs and pharmaceutical dosage forms containing them are provided.

Career Highlights

Imre M Vitez is associated with Bristol-Myers Squibb Company, where he has been instrumental in advancing pharmaceutical research. His work focuses on enhancing the efficacy and stability of drug formulations through polymorphic variations.

Collaborations

Throughout his career, Imre has collaborated with esteemed colleagues, including John D DiMarco and Jack Z Gougoutas. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.

Conclusion

Imre M Vitez's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to impact therapeutic methods and drug formulations significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…